SCHEMBL18901147

SCHEMBL18901147

CCc1nnc(CN)o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8388694 0.86
SCHEMBL20755077 0.86
SCHEMBL1785878 0.80 POLB (0.36)
SCHEMBL28300320 0.75 MAPT (0.44)
SCHEMBL12845869 0.74
SCHEMBL2040652 0.74
Hydrochloric Acid SCHEMBL15464406 0.72
SCHEMBL10273176 0.70
SCHEMBL762438 0.70
SCHEMBL13193928 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154344-A1 2-METHYL-4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-THIENO[2,3-C]PYRAN] DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-08-17 WO disclosed
WO-2019027890-A1 METHODS FOR TREATING MYELOSUPPRESSION GAFFNEY KEVIN J (US) 2019-02-07 WO disclosed
EP-3016951-B1 TRICYCLIC PYRIDO-CARBOXAMIDE DERIVATIVES AS ROCK INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-05-31 EP disclosed